TOP2A and CHEK1 were found to be significantly correlated with the prognosis of patients with TCGA-COAD (Figure 3F, 3G), indicating that both of them had the potential to be biomarkers for the prognosis of CRC. Here, CHEK1 is linked to colorectal carcinoma.